Researchers have identified a protein that may help aggressive triple-negative breast cancer spread to the brain and survive once it gets there. The preclinical findings could point toward new ...

TNBC is a type of invasive breast cancer that doesn’t have hormone receptors or HER2 proteins. Though treatment options for TNBC depend on several factors, they often include surgery, chemotherapy, ...

Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancer diagnoses but accounts for a disproportionately high percentage of breast cancer deaths. What sets this ...

A deeper understanding of mitochondrial function could create new opportunities for treating triple-negative breast cancer ...

Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast ...

COLD SPRING HARBOR, N.Y., June 30, 2025 /PRNewswire/ -- Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, it's also one of ...

New research shows that triple-negative breast cancer cells rely on shared DNA damage tolerance enzymes such as POLζ and CHK1 ...

Policy changes supporting breastfeeding may address structural barriers and lower overall incidence and racial disparities surrounding TNBC in the US. Better support for breastfeeding may help avoid ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other ...

Expression of α-basic-crystallin – Expressed in approximately 50% 33 Increased versus other intrinsic types * BLBC—variously defined (that is not restricted to tumors defined on gene-expression ...